Anti-relapse medications: preclinical models for drug addiction treatment.
about
The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in ratsNovel cues reinstate cocaine-seeking behavior and induce Fos protein expression as effectively as conditioned cues.AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic futureD-serine treatment reduces cocaine-primed reinstatement in rats following extended access to cocaine self-administration.Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effectsPharmacotherapeutic approach to the treatment of addiction: persistent challengesPharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seekingEndocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats.Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats.Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus.Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.Development of κ opioid receptor antagonists.The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behaviorSex differences in methamphetamine seeking in rats: impact of oxytocin.The hypocretin/orexin system: implications for drug reward and relapse.Assessment of a proposed "three-criteria" cocaine addiction model for use in reinstatement studies with rats.Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories--indications for novel treatments of addiction.Targeting GABAB receptors for anti-abuse drug discovery.Modeling the development of drug addiction in male and female animals.Recent developments in the behavioural and pharmacological enhancement of extinction of drug seeking.Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats.Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans.
P2860
Q28267531-6A5A24EC-9F4D-4441-B945-F23A977942BCQ30451633-654A3400-8F49-4B34-A916-C7BDF887A1A0Q33995795-1F375D36-B065-4122-846C-2F0C876629D0Q34036997-BD4D241C-B1D7-432C-B395-472E34D6A6A4Q34216479-2DC83A32-349C-4801-B37E-19FD5F9A9892Q34242078-F0F04248-9F9A-425B-A1A9-0A3069756D3FQ34253787-F3332BFD-25F1-47B8-9A6C-6A179EB40EBDQ34673305-CD998936-8928-4CE8-9933-F5907F307F1AQ34795068-8621D6E8-CF90-479F-A47D-412D89C0DCBCQ34868089-FBC01EFD-56C8-43D4-8EBE-DE5C46093E72Q35532072-F8F666E9-B808-4D80-A99E-51D87015D47CQ35673212-8E6E5577-4CF0-435E-A93C-F7B1855841B4Q35688532-8CDCBE34-4961-4703-8301-95C79F0924E9Q35819948-82CFD17F-30D8-464D-8CD6-DF32438F19D3Q35833732-460B6B3A-86E2-43CC-92F1-7749B61B6301Q36014803-3C6D189D-ADE0-4890-BDB3-EBF05FB6B45AQ36303094-57C069D6-A980-416F-8AE5-39587B573B70Q36728154-EBC7BF3F-69F3-404F-8E97-05B743439EB2Q36775245-7462500E-6DD2-4415-9351-D7B28D936D5BQ37179247-0B3685B2-B911-40E0-9AC3-E91B065202B0Q37995046-918D4274-9C98-4C3F-BE07-061D76F87851Q38194926-624E7467-030F-4FAE-917E-A64DCD9C14A0Q38220754-9ABB5E07-8F82-439A-AE97-3EE5DDF5BA17Q38246629-8B611EB3-E9EB-4035-A055-1025CAB943DCQ38669858-CFA712F0-8171-4695-B27A-51262E2D72E2Q38674558-E895AC1A-F60A-4E7F-8FE6-CCEB87B83E31Q38862631-61E4C9AF-7520-48D1-978F-26714B91CF91Q42670258-B8C7B5DD-F4E3-411A-8E98-604A293A7FFF
P2860
Anti-relapse medications: preclinical models for drug addiction treatment.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anti-relapse medications: preclinical models for drug addiction treatment.
@ast
Anti-relapse medications: preclinical models for drug addiction treatment.
@en
type
label
Anti-relapse medications: preclinical models for drug addiction treatment.
@ast
Anti-relapse medications: preclinical models for drug addiction treatment.
@en
prefLabel
Anti-relapse medications: preclinical models for drug addiction treatment.
@ast
Anti-relapse medications: preclinical models for drug addiction treatment.
@en
P2860
P1476
Anti-relapse medications: preclinical models for drug addiction treatment.
@en
P2093
Noushin Yahyavi-Firouz-Abadi
Ronald E See
P2860
P304
P356
10.1016/J.PHARMTHERA.2009.06.014
P577
2009-08-13T00:00:00Z